iShares U.S. Medical Devices ETF
Health/Biotechnology
IHI
400 Howard Street,
San Francisco , CA, 94105
San Francisco , CA, 94105
Price
-
$ 64.84
0 %
+0.59
Feb 19, 2025
- Last Close
- Net Assets
-
$5.4B
Feb 23, 2024
- 52-Week High/Low
- $65.09 - $54.36
- Expense Ratio
- -
Link
Directors
Jun 14, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Charles Park
Company Name |
Holding |
| More | 0.33 % |
Documents
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Q1 | - | 8.6% | 2.7% | -7.3% | 0.8% | -14.3% |
| Q2 | - | -0.2% | 4.6% | -17.3% | 9.6% | 17.5% |
| Q3 | - | - | -14.1% | -6.5% | 4.1% | -81.2% |
| Q4 | - | - | 11.8% | 11.4% | 5% | 9.4% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 3.5% | 1.8% | 3.1% | -6.1% | 1.9% | - | - | - | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 2.9% | 2.7% | -20.1% | 20.7% | -79.3% | 31.6% | 15.5% | 30.8% | 9.3% | 9.7% |